{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:24:02Z","timestamp":1791224642150,"version":"4.1.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jcv.2012.08.022","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T06:45:17Z","timestamp":1348209917000},"page":"296-302","source":"Crossref","is-referenced-by-count":73,"title":["Viral hepatitis: Global goals for vaccination"],"prefix":"10.1016","volume":"55","author":[{"given":"Daniel","family":"Lavanchy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2012.08.022_bib0005","first-page":"38","article-title":"Hepatitis A vaccines. WHO position paper","volume":"75","year":"2000","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jcv.2012.08.022_bib0010","series-title":"Hepatitis A. The immunological basis for immunization series. Module 18","author":"Shouval","year":"2011"},{"key":"10.1016\/j.jcv.2012.08.022_bib0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3201\/eid0505.990502","article-title":"Food-related illness and death in the United States","volume":"5","author":"Mead","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jcv.2012.08.022_bib0020","first-page":"21","article-title":"HAV epidemiology in the southern hemisphere","volume":"7","author":"Cheinquer","year":"2007","journal-title":"Hot Top Viral Hepat"},{"key":"10.1016\/j.jcv.2012.08.022_bib0025","first-page":"63","article-title":"Antibodies against hepatitis A in different European countries. I. Comparison of prevalence data in different age groups","volume":"110","author":"Frosner","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2012.08.022_bib0030","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/0264-410X(92)90546-V","article-title":"Epidemiology of hepatitis A in Mediterranean countries","volume":"10","author":"Papaevangelou","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0035","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.1994.03520110065031","article-title":"Epidemiology and prevention of hepatitis A in travelers","volume":"272","author":"Steffen","year":"1994","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"10.1016\/j.jcv.2012.08.022_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2008.01022.x","article-title":"Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology","volume":"15","author":"Hendrickx","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jcv.2012.08.022_bib0045","series-title":"Foodborne disease outbreaks: guidelines for investigation and control","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.jcv.2012.08.022_bib0050","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jcv.2012.08.022_bib0055","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/jmv.21883","article-title":"Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine","volume":"82","author":"Bovier","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0060","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0264-410X(02)00042-7","article-title":"Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years\u2019 followup after the Monroe field trial of VAQTA","volume":"20","author":"Werzberger","year":"2002","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.jcv.2012.08.022_bib0065","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0168-8278(05)80378-2","article-title":"Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial","volume":"18","author":"Werzberger","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0070","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jama.1994.03510410040030","article-title":"Protection against hepatitis A by an inactivated vaccine","volume":"271","author":"Innis","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2012.08.022_bib0075","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(03)14418-2","article-title":"Hepatitis A booster vaccination: is there a need?","volume":"362","author":"Van Damme","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2012.08.022_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2012.04.104","article-title":"Long-term protective effects of hepatitis A vaccines. A systematic review","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2310\/7060.2004.18479","article-title":"Do we need hepatitis A booster vaccinations?","volume":"11","author":"Van Damme","year":"2004","journal-title":"J Travel Med"},{"key":"10.1016\/j.jcv.2012.08.022_bib0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jama.294.2.246","article-title":"Effect of hepatitis A vaccination programs","volume":"294","author":"Van Damme","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2012.08.022_bib0095","first-page":"33","article-title":"Vaccination against hepatitis A: a review of the evidence","volume":"7","author":"Bonanni","year":"2007","journal-title":"Hot Top Viral Hepat"},{"key":"10.1016\/j.jcv.2012.08.022_bib0100","series-title":"International travel and health 2008","year":"2008"},{"key":"10.1016\/j.jcv.2012.08.022_bib0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2310\/7060.2004.19013","article-title":"Accelerated vaccination schedules provide protection against hepatitis A and B in last-minute travelers","volume":"11","author":"Nothdurft","year":"2004","journal-title":"J Travel Med"},{"key":"10.1016\/j.jcv.2012.08.022_bib0110","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"CDC","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jcv.2012.08.022_bib0115","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa070546","article-title":"Hepatitis A vaccine versus immune globulin for postexposure prophylaxis","volume":"357","author":"Victor","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2012.08.022_bib0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S0950268898001411","article-title":"Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy","volume":"121","author":"Bonanni","year":"1998","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jcv.2012.08.022_bib0125","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.vaccine.2005.01.044","article-title":"Vaccination against hepatitis A during outbreaks starting in schools: what can we learn from experiences in central Italy?","volume":"23","author":"Bonanni","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0130","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"CDC","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jcv.2012.08.022_bib0135","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archpedi.1996.02170320079014","article-title":"A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine","volume":"150","author":"McMahon","year":"1996","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jcv.2012.08.022_bib0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jmv.1890440427","article-title":"Interruption of an outbreak of hepatitis A in two villages by vaccination","volume":"44","author":"Prikazsky","year":"1994","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0145","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.vaccine.2007.11.016","article-title":"Hepatitis A vaccination effectiveness during an outbreak in the Ukraine","volume":"26","author":"Selnikova","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s100960100461","article-title":"Control of a community-wide outbreak of hepatitis A by mass vaccination with inactivated hepatitis A vaccine","volume":"20","author":"Zamir","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jcv.2012.08.022_bib0155","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1016\/j.vaccine.2004.04.014","article-title":"Quantifying the impact of hepatitis A immunization in the United States, 1995\u20132001","volume":"22","author":"Samandari","year":"2004","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2012.08.022_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2007.00924.x","article-title":"Hepatitis A and B vaccination and public health","volume":"14","author":"Hollinger","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jcv.2012.08.022_bib0165","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0140-6736(98)01304-X","article-title":"Hepatitis A","volume":"351","author":"Koff","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2012.08.022_bib0170","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/clinchem\/43.8.1494","article-title":"Type A viral hepatitis: epidemiology, diagnosis, and prevention","volume":"43","author":"Lemon","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.jcv.2012.08.022_bib0175","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.294.2.202","article-title":"Incidence of hepatitis A in Israel following universal immunization of toddlers","volume":"294","author":"Dagan","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2012.08.022_bib0180","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/bmj.332.7543.715","article-title":"Should all children be immunised against hepatitis A?","volume":"332","author":"Temte","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2012.08.022_bib0185","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(05)00384-7","article-title":"Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention","volume":"34","author":"Lavanchy","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0190","series-title":"Estimating the global burden of hepatitis B","author":"Gay","year":"2001"},{"key":"10.1016\/j.jcv.2012.08.022_bib0195","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jcv.2012.08.022_bib0200","first-page":"801","article-title":"Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates","volume":"77","author":"Kane","year":"1999","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.jcv.2012.08.022_bib0205","first-page":"361","article-title":"Global status of immunization safety: report based on the WHO\/UNICEF joint reporting","volume":"80","author":"WHO","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jcv.2012.08.022_bib0210","first-page":"1","article-title":"Hepatitis B vaccination: safety issues","volume":"12","author":"VHPB (Viral Hepatitis Prevention Board)","year":"2003","journal-title":"Viral Hepat"},{"key":"10.1016\/j.jcv.2012.08.022_bib0215","series-title":"Sharps injuries: global burden of disease from sharps injuries to health-care workers. WHO Environmental Burden of Disease Series","author":"Pr\u00fcss-Ust\u00fcn","year":"2003"},{"key":"10.1016\/j.jcv.2012.08.022_bib0220","first-page":"787","article-title":"Injection safety: a global challenge","volume":"77","author":"Hutin","year":"1999","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.jcv.2012.08.022_bib0225","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0140-6736(02)09284-X","article-title":"Unsterile injections and emergence of human pathogens","volume":"359","author":"Hutin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2012.08.022_bib0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7326\/0003-4819-142-5-200503010-00008","article-title":"Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up","volume":"142","author":"McMahon","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcv.2012.08.022_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kjms.2011.10.027","article-title":"Towards the eradication of hepatitis B in Taiwan","volume":"28","author":"Wait","year":"2012","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jcv.2012.08.022_bib0240","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10552-010-9721-4","article-title":"Reduction of hepatocellular carcinoma in childhood after introduction of selective vaccination against hepatitis B virus for infants born to HBV carrier mothers","volume":"22","author":"Tajiri","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jcv.2012.08.022_bib0245","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1158\/1055-9965.EPI-08-0303","article-title":"20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer","volume":"17","author":"Viviani","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jcv.2012.08.022_bib0250","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1542\/peds.99.3.351","article-title":"Hepatitis B vaccination and hepatocellular carcinoma in Taiwan","volume":"99","author":"Lee","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcv.2012.08.022_bib0255","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0264-410X(02)00580-7","article-title":"Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy","volume":"21","author":"Bonanni","year":"2003","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2012.08.022_bib0260","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0168-8278(03)00269-1","article-title":"Impact of hepatitis B immunization, Europe and worldwide","volume":"39","author":"Namgyal","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0265","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1016\/S0264-410X(01)00120-7","article-title":"The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds","volume":"19","author":"Tsebe","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0270","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/jnci\/djp288","article-title":"Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study","volume":"101","author":"Chang","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcv.2012.08.022_bib0275","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/epirev\/mxj010","article-title":"Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched","volume":"28","author":"Chien","year":"2006","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.jcv.2012.08.022_bib0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1034\/j.1478-3231.2003.00865.x","article-title":"Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization","volume":"23","author":"Chang","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.jcv.2012.08.022_bib0285","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.inf.0000183853.16113.a6","article-title":"Vaccine safety controversies and the future of vaccination programs","volume":"24","author":"Francois","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcv.2012.08.022_bib0290","first-page":"907","article-title":"Hepatitis B vaccines and immunization","volume":"vol. 1","author":"Lavanchy","year":"2007"},{"key":"10.1016\/j.jcv.2012.08.022_bib0295","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","article-title":"Are booster immunisations needed for lifelong hepatitis B immunity?","volume":"355","author":"European Consensus Group on Hepatitis B Immunity","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2012.08.022_bib0300","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.vaccine.2005.03.017","article-title":"Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants","volume":"23","author":"FitzSimons","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0305","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(05)67568-X","article-title":"Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study","volume":"366","author":"Zanetti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2012.08.022_bib0310","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1440-1746.2004.03398.x","article-title":"Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations?","volume":"20","author":"John","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2012.08.022_bib0315","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0168-8278(03)00152-1","article-title":"Hepatitis B vaccines","volume":"39","author":"Shouval","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0320","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"73","author":"Kidney Disease Improving Global Outcomes","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcv.2012.08.022_bib0325","first-page":"1","article-title":"Combined hepatitis B vaccines","volume":"10","author":"VHPB (Viral Hepatitis Prevention Board)","year":"2002","journal-title":"Viral Hepatitis"},{"key":"10.1016\/j.jcv.2012.08.022_bib0330","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0264-410X(02)00461-9","article-title":"Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand","volume":"21","author":"Chunsuttiwat","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0335","first-page":"864","article-title":"A new combined DTP-HBV-Hib vaccine\u2014strategy for incorporation of Hib vaccination into childhood immunisation programmes","volume":"91","author":"Ramkissoon","year":"2001","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jcv.2012.08.022_bib0340","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0264-410X(00)00403-5","article-title":"A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity","volume":"19","author":"Nolan","year":"2001","journal-title":"Vaccine"},{"issue":"Suppl.","key":"10.1016\/j.jcv.2012.08.022_bib0345","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0264-410X(98)00301-6","article-title":"Current combined vaccines with hepatitis B","volume":"16","author":"Papaevangelou","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0350","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1086\/323396","article-title":"Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy","volume":"184","author":"Mele","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2012.08.022_bib0355","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jmv.1890180405","article-title":"Multicenter trial on the efficacy of HBIG and vaccine in preventing perinatal hepatitis B. Final report","volume":"18","author":"Zanetti","year":"1986","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0360","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0029-7844(02)02000-8","article-title":"Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers","volume":"99","author":"Hill","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0365","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1016\/S0264-410X(02)00358-4","article-title":"Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand","volume":"20","author":"Lolekha","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0370","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1086\/315259","article-title":"Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program","volume":"181","author":"Harpaz","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2012.08.022_bib0375","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.1988.03410150079034","article-title":"Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers","volume":"260","author":"Hsu","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2012.08.022_bib0380","series-title":"Vaccines","first-page":"158","article-title":"Hepatitis B vaccine","author":"Mahoney","year":"1999"},{"key":"10.1016\/j.jcv.2012.08.022_bib0385","first-page":"2971","article-title":"Hepatitis B virus","volume":"vol. 4","author":"Hollinger","year":"2001"},{"key":"10.1016\/j.jcv.2012.08.022_bib0390","first-page":"389","volume":"77","author":"Global Advisory Committee on Vaccine Safety","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jcv.2012.08.022_bib0395","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jama.282.1.15-JMN0707-3-1","article-title":"Debate revived on hepatitis B vaccine value","volume":"282","author":"Marwick","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2012.08.022_bib0400","first-page":"149","article-title":"Expanded Programme on Immunization (EPI). Lack of evidence that hepatitis B vaccine causes multiple sclerosis","volume":"72","author":"WHO","year":"1997","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jcv.2012.08.022_bib0405","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200102013440502","article-title":"Hepatitis B vaccination and the risk of multiple sclerosis","volume":"344","author":"Ascherio","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl.1","key":"10.1016\/j.jcv.2012.08.022_bib0410","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0168-8278(03)00153-3","article-title":"Safety of immunization and adverse events following vaccination against hepatitis B","volume":"39","author":"Duclos","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0415","series-title":"State of the world's vaccines and immunization","author":"WHO, UNICEF, World Bank","year":"2009"},{"key":"10.1016\/j.jcv.2012.08.022_bib0420","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jhep.2009.09.010","article-title":"Europe's hepatitis challenge: defusing the \u201cviral time bomb\u201d","volume":"51","author":"Piorkowsky","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0425","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/0264-410X(95)80050-N","article-title":"Global programme for control of hepatitis B infection","volume":"13","author":"Kane","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0430","first-page":"1","article-title":"Prevention and control of hepatitis B in the community","volume":"1","author":"Grosheide","year":"1996","journal-title":"Commun Dis Ser"},{"key":"10.1016\/j.jcv.2012.08.022_bib0435","series-title":"Hepatitis B control through immunization","author":"Scientific Advisory Group of Experts (SAGE)","year":"1996"},{"key":"10.1016\/j.jcv.2012.08.022_bib0440","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0887-7963(90)70264-7","article-title":"Control of hepatitis B virus infection in Third-World countries","volume":"4","author":"Prince","year":"1990","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jcv.2012.08.022_bib0445","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CMR.12.2.351","article-title":"Update on diagnosis, management, and prevention of hepatitis B virus infection","volume":"12","author":"Mahoney","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcv.2012.08.022_bib0450","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0168-8278(02)00213-1","article-title":"Results of an enhanced-outreach programme of hepatitis B vaccination in the Netherlands (1998\u20132000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners","volume":"37","author":"van Steenbergen","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0455","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0264-410X(93)90222-J","article-title":"Vaccination against hepatitis B: the Italian strategy","volume":"11","author":"Zanetti","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0460","series-title":"Medical microbiology","first-page":"849","article-title":"Hepatitis viruses","author":"Zuckerman","year":"1996"},{"key":"10.1016\/j.jcv.2012.08.022_bib0465","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2012.08.022_bib0470","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0168-8278(00)80132-4","article-title":"The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy","volume":"33","author":"Stroffolini","year":"2000","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2012.08.022_bib0475","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/0264-410X(95)93557-P","article-title":"Implementing universal vaccination programmes: Bulgaria","volume":"13","author":"Gatcheva","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0605","series-title":"Immunization summary. A statistical reference containing data through 2010","author":"UNICEF & WHO","year":"2012"},{"key":"10.1016\/j.jcv.2012.08.022_bib0610","series-title":"Global Immunization Vision and Strategy 2006\u20132015","author":"UNICEF & WHO","year":"2005"},{"key":"10.1016\/j.jcv.2012.08.022_bib0490","first-page":"335","article-title":"Vaccination contre l\u2019h\u00e9patite B en Suisse: vers une strat\u00e9gie globale","volume":"118","author":"Kammerlander","year":"1998","journal-title":"Rev Med Suisse Romande"},{"key":"10.1016\/j.jcv.2012.08.022_bib0495","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2003-37583","article-title":"Epidemiology and prevention of hepatitis B","volume":"23","author":"Alter","year":"2003","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jcv.2012.08.022_bib0500","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0264-410X(98)00286-2","article-title":"Universal hepatitis B immunization: infant, and infant plus adolescent immunization","volume":"16","author":"Bonanni","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0505","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0264-410X(98)00287-4","article-title":"Universal hepatitis B immunization: young adolescent immunization","volume":"16","author":"Tepper","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0510","unstructured":"WHO Hepatitis B immunization. Introducing hepatitis B into national immunization services. Fact sheet WHO\/V&B\/01 2001."},{"key":"10.1016\/j.jcv.2012.08.022_bib0515","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2471\/BLT.04.017426","article-title":"Improving birth dose coverage of hepatitis B vaccine","volume":"84","author":"Hipgrave","year":"2006","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.jcv.2012.08.022_bib0520","series-title":"Getting started with vaccine vial monitors","year":"2002"},{"issue":"Suppl. 3","key":"10.1016\/j.jcv.2012.08.022_bib0525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0264-410X(99)00293-5","article-title":"Lessons from the eradication campaigns","volume":"17","author":"Henderson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2012.08.022_bib0530","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00006454-199908000-00005","article-title":"Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy","volume":"18","author":"Bonanni","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2012.08.022_bib0535","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jcv.2012.08.022_bib0540","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2010.00977.x","article-title":"Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses","volume":"239","author":"Houghton","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jcv.2012.08.022_bib0545","doi-asserted-by":"crossref","first-page":"115fs1","DOI":"10.1126\/scitranslmed.3003526","article-title":"Chimp virus makes a savvy vaccine vector","volume":"4","author":"Houghton","year":"2012","journal-title":"Sci Transl Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2012.08.022_bib0550","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/cid\/cis362","article-title":"Prospects for prophylactic and therapeutic vaccines against hepatitis C virus","volume":"55","author":"Feinstone","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2012.08.022_bib0555","series-title":"Diseases of the liver","first-page":"863","article-title":"Hepatitis D","author":"Rizzetto","year":"2002"},{"key":"10.1016\/j.jcv.2012.08.022_bib0560","series-title":"The global prevalence of hepatitis E virus infection and susceptibility: a systematic review","author":"Aggarwal","year":"2010"},{"key":"10.1016\/j.jcv.2012.08.022_bib0565","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2007.12.008","article-title":"Hepatitis E: an emerging awareness of an old disease","volume":"48","author":"Purcell","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcv.2012.08.022_bib0570","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2012.08.022_bib0575","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa061847","article-title":"Safety and efficacy of a recombinant hepatitis E vaccine","volume":"356","author":"Shrestha","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2012.08.022_bib0580","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2012.08.022_bib0585","series-title":"World's first hepatitis E vaccine approved in China","author":"Pagliusi","year":"2012"},{"key":"10.1016\/j.jcv.2012.08.022_bib0590","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nbt0412-300a","article-title":"First HEV vaccine approved","volume":"30","author":"Proffitt","year":"2012","journal-title":"Nat Biotech"},{"key":"10.1016\/j.jcv.2012.08.022_bib0595","first-page":"405","article-title":"Hepatitis B immunization. WHO position paper","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jcv.2012.08.022_bib0600","first-page":"329","article-title":"Hepatitis B immunization. WHO position paper","volume":"73","year":"1998","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653212003265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653212003265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T02:01:20Z","timestamp":1594692080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653212003265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":120,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1386653212003265"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2012.08.022","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}